Tuberculosis (TB) at UCL
UCL-TB connects researchers in UCL and across their networks with the aim of improving research into TB, dissemination of research outcomes and new funding opportunities for research groups.
North London TB Journal Club
Monday, 9 November, 2013 - 12 midday
Use of next generation sequencing and the identification of resistance sites in the Mtb genome.
Paper: “Genomic analysis identifies targets of convergent positive
selection in drug-resistant Mycobacterium tuberculosis.”
Nat Genet. 2013 Oct;45(10):1183-9. doi: 10.1038/ng.2747 (LINK)
The paper will be backed up by two more from the same journal:
- “Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance” , Nat Genet. 2013 Oct;45(10):1255-60. doi: 10.1038/ng.2735, (ABSTRACT) and
-“Evolution of high-level
ethambutol-resistant tuberculosis through interacting mutations in
decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes”, Nat Genet.
2013 Oct;45(10):1190-7. doi: 10.1038/ng.2743. (ABSTRACT)
Dimitrios will also mention data from his own paper which is in press on the application of next generation sequencing in Mtb.
Chair: Professor Tim McHugh
Presenter: Dimitrios Evangelopoulos
Venue: Tutorial Room 3 (TR3), Royal Free Hospital, Hampstead.
TBTEAM TA request: epidemiologist in Timor-Leste
TBTEAM is seeking a TB epidemiologist to conduct a comprehensive epidemiological situation assessment of TB in Timor-Leste.
More information: http://www.stoptb.org/countries/tbteam/viewMission.asp?MID=5344
Deadline for applications is 1 October.
If interested, please send cv to Dr. Lungten Z. Wangchuk (firstname.lastname@example.org).
Thursday, 17 October, 6.30pm, LSHTM
THE FINAL FRONTIER: Treating Drug-resistant TB
Film and panel discussion
This event, hosted by Médecins Sans Frontières/Doctors Without Borders (MSF), sets out what can be done today and what is still needed to end the crisis of TB. MSF works at the front-line of the DR-TB crisis in 21 countries around the world.
"The Final Frontier" shares our experience and learning in three areas:
- Growing global health crisis
- Evidence for improving patient outcomes
- Historic opportunity for a new treatment regimen
- Professor Andrew Nunn, MRC Associate Director & Chair of Infections Research Theme
- Dr Grania Bridgen, TB Advisor for MSF's Access Campaign (tbc)
- Chief Austin Obiefuna, Southern CSO Representative on Stop TB Partnership Coordinating Board and founder of Afro Global Alliance.
Venue: Jon Snow Lecture Theatre, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
If you are interested in attending this event, please RSVP at email@example.com
MAMS-TB trial (Multi-arm-multi-stage-TB): leading European and African clinicians commence a new trial that may lead to shorter tuberculosis treatment. [May 2013]
The PanACEA consortium (Pan African Consortium for the
Evaluation of Anti-tuberculosis agents) have started recruiting patients to an innovative
new clinical trial of tuberculosis (TB) treatments. The aim of this trial is to identify new
treatment regimens that could significantly shorten the length of therapy from
six months to three months. The trial is
being conducted in Tanzania and South Africa and uses a new approach that could
reduce the time taken to bring the treatment to market. The MAMS-TB trial (Multi-arm-multi-stage -TB)
uses a combination of established drugs and novel drugs and is funded by the
European Developing Country Clinical Trials Partnership (EDCTP). [Download the press release]
UCL WORLD TB DAY EVENT 2013
This week's World TB Day event at the Royal Free invited speakers to talk about targetting zero deaths from TB. A selection of photographs from the event is available here (LINK) with copies speakers' presentations and a blogger's account to come shortly. (27 March).
Professor Tim McHugh: Inaugural Lecture (December 2012)
Professor McHugh delivered his inaugural lecture at UCL on 13 December, 2012, on the challenges of drug resistant TB. Link to video of lecture.
Professor Alimuddin Zumla: Presidential Award
Professor Ali Zumla has been awarded the Zambian Order of Distinguished Service (First Division) by the President of Zambia during the Zambia presidential award investiture ceremony on 24 October, during Zambia's independence day celebrations, at the Presidential State House in Lusaka. The award was made to recognise Professor Zumla's considerable achievements in medicine and international development.
Tell us about your latest projects and events related to TB or ask us a question about TB.
Our email is firstname.lastname@example.org.
Join the mailing list
Page last modified on 29 jan 13 15:14